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Background and purpose: Clinical management after transient ischaemic
attack (TIA) is focused on stroke prevention; however, a number of small
studies suggest that patients may experience ongoing residual impairments.
Methods: This was a retrospective matched-cohort study using anonymized
electronic primary care records from The Health Improvement Network data-
base, which covers approximately 6% of the UK population. Adults
(≥ 18 years old) who experienced a ﬁrst TIA between 2009 and 2013 were
matched in a ratio of 1:5 to controls by age, sex and general practice. The
time to ﬁrst consultation for fatigue, psychological impairment or cognitive
impairment was estimated by Kaplan–Meier survivor functions and adjusted
hazard ratios.
Results: A total of 9419 TIA patients and 46 511 controls were included. The
Kaplan–Meier curves showed that TIA patients were more likely than controls
to consult for all three impairments (P < 0.0001). Within 7.1 months (95%
conﬁdence interval (CI), 6.2–8.2), 25% of TIA patients consulted for psycho-
logical impairment compared with 23.5 months (95% CI, 22.5–24.6) for con-
trols. Hazard ratios for TIA patients were 1.43 (95% CI, 1.33–1.54) for
consulting for fatigue, 1.26 (95% CI, 1.20–1.31) for psychological impairment
and 1.45 (95% CI, 1.28–1.65) for cognitive impairment.
Conclusions: Transient ischaemic attack is associated with signiﬁcantly
increased subsequent consultation for fatigue, psychological impairment and
cognitive impairment. These ﬁndings suggest that impairments exist after ini-
tial symptoms of TIA have resolved, which should be considered by clinicians
when treating TIA patients.
Introduction
Transient ischaemic attack (TIA) is clinically impor-
tant because patients have increased risk of having a
full stroke [1]. TIAs are common and incidence has
increased over the past two decades [2]; approximately
46 000 people experience a ﬁrst TIA each year and
there are 510 000 people living with a history of TIA
in the UK [3]. Historically, TIA was diﬀerentiated
from stroke using a time-based deﬁnition (symptoms
lasting less than 24 h). However, following advances
in imaging, this was reclassiﬁed to a tissue-based deﬁ-
nition (a brief episode of neurologic dysfunction with-
out evidence of acute infarction) [4]. Despite this,
brain imaging is not routinely used to diagnose TIA
and diagnosis is based on clinical history [5].
Guidelines relevant to TIA promote rapid evalua-
tion of patients with suspected TIA and focus on
diagnosis, determining the aﬀected vascular territory
and assessing stroke risk [5,6]. Follow-up for TIA
patients is focused on management of stroke risk fac-
tors through medical, surgical and lifestyle interven-
tions [5]. Clinical guidelines recognize that stroke
patients may experience ongoing impairments that
require rehabilitation; however, these guidelines do
not extend to TIA [5,7].
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The long-term impact of TIA is unclear and the
UK’s leading stroke charity, Stroke Association, rec-
ommended the investigation of this as a research pri-
ority in their TIA campaign report (2014) [8]. Our
systematic review, which investigated the prevalence
of fatigue, psychological and cognitive impairment
after TIA and minor stroke [9], suggests a relatively
high prevalence of cognitive impairment and depres-
sion post-TIA/minor stroke. However, very few stud-
ies had a control group and we were unable to
determine whether the prevalence of these impair-
ments was higher than in people of a similar age with-
out TIA/minor stroke. If patients experience ongoing
residual impairments after TIA, these impairments
could impact on their health, wellbeing and ability to
return to work and social activities. Our study aimed
to investigate the association between TIA and con-
sultation for fatigue, psychological impairment or cog-
nitive impairment in primary care.
Methods
The full protocol for this study has been published
elsewhere [10]; the methods are summarized in brief
below.
Study design and data source
This was a retrospective matched-cohort study of
ﬁrst-ever TIA patients using anonymized, routinely
collected, primary care data from The Health
Improvement Network (THIN) database [11]. This
database is broadly representative of the UK popula-
tion, with approximately 6% coverage [11] and diag-
nosis of TIA has been validated in THIN [12]. Data
are extracted from contributing general practices using
Vision patient records software [11]. Analysis of
THIN data is ethically approved by the National
Health Service South-East Multi-centre Research
Ethics Committee subject to independent scientiﬁc
review [13]. This study received approval by a Scien-
tiﬁc Review Committee in February 2014 (reference
no. 14-008).
Population
The population consisted of patients aged 18 years
and over with a ﬁrst-ever diagnosis of TIA between
January 2009 and December 2013. TIA patients
would have been diagnosed according to the UK
National Institute for Health and Care Excellence
guidelines, which deﬁne TIA as ‘stroke symptoms and
signs that resolve within 24 h’ [5]. In accordance with
these guidelines, brain imaging is not routine;
however, it is recommended when the vascular terri-
tory or pathology is uncertain [5]. TIA patients were
matched with up to ﬁve TIA-free controls [14] on:
year of birth ( 2 years), sex, general practice and
date of TIA (index date). TIA patients and controls
were free from stroke at baseline. The index date must
have occurred at least 1 year after the general practice
began using Vision patient records software and after
the date of acceptable mortality recording (markers of
data quality) [15]. TIA patients and matched controls
had to be registered at their general practice for at
least 1 year prior to the index date to allow baseline
data to be recorded by their practice and had to have
remained alive and registered for at least 1 month
after the index date to allow time for the outcomes of
interest to be recorded.
Variables
There were three separate substudies for the ﬁrst con-
sultation after the index date with a record of (i) fati-
gue, (ii) psychological impairment [comprised of
anxiety, depression and post-traumatic stress disorder
(PTSD)] or (iii) cognitive impairment. These outcomes
were deﬁned by appropriate clinical codes for diag-
noses and symptoms. In addition, a ﬁrst prescription
of an antidepressant or antianxiety drug was used to
deﬁne psychological impairment. Cognitive impair-
ment included memory, attention, spatial awareness,
perception, apraxia and executive functioning impair-
ments but not a diagnosis of dementia [16]. Cognitive
impairment was deﬁned by Read codes for diagnoses
(such as 28E0.00: mild cognitive impairment) and
symptoms (such as 1B1A.12: memory loss symptom)
related to overall cognitive impairment and impaired
individual cognitive domains [9]. Overall cognitive
impairment and impaired individual cognitive
domains were evaluated as one outcome. For each
substudy, follow-up continued until the ﬁrst consulta-
tion for the relevant outcome (e.g. consultation for
fatigue in the fatigue substudy). Censoring occurred at
the ﬁrst occurrence of: death, stroke, the patient leav-
ing the practice or the last data collection from the
general practice. Diagnosis of TIA in the follow-up
was permitted for TIA patients but controls were cen-
sored at the date that a TIA diagnosis was recorded
and subsequently became eligible for inclusion in the
TIA group.
Potential confounding variables were identiﬁed
using the most recent baseline demographic and clini-
cal characteristics prior to the index date. These
included age, sex, body mass index, Townsend depri-
vation, urban/rural residence, smoking status, alcohol
consumption and comorbidities. Comorbidities
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comprised the chronic conditions included in the UK
chronic disease quality monitoring programme, the
Quality and Outcomes Framework (business rules ver-
sion 27; see Table 1) [17]. Numbers of consultations
in the follow-up were included because patients who
consult more have more opportunities to report resid-
ual impairments. To control for presence of the out-
comes at baseline, the most recent consultations prior
to the index date for fatigue, psychological impair-
ment or cognitive impairment were extracted.
Quality checks, missing data and extreme values
The absence of a clinical code or relevant drug code
for an individual diagnosis prior to the index date was
taken to indicate that the diagnosis was not present.
For clinical measurements (height, weight and body
mass index), implausible values were excluded based
on pre-deﬁned cut-oﬀ scores (Supporting Information
Table S1). As data are unlikely to be missing at ran-
dom [18], no attempt was made to impute numeric
missing data. Instead, variables were categorized and
a separate ‘missing’ category was created. Data were
initially extracted between 2000 and 2013; however,
there was evidence of under-reporting of TIA before
2008, with the number of incident TIA events before
2008 less than 15% of recorded TIA after 2009 (Sup-
porting Information Fig. S1). After 2009, this was
more stable and therefore only patients with a TIA
recorded from 1 January 2009 were included.
Analysis
All analysis was conducted using STATA version 12
(StataCorp, College Station, TX, USA). The study
was an open cohort and therefore Kaplan–Meier
(K-M) survivor functions were used to estimate time
to consultation for each outcome and log rank tests
compared survivor functions of TIA patients and con-
trols. Cox proportional hazard models adjusted for
potential confounding of demographic and clinical
characteristics. Inclusion of covariates in the model
was selected using backwards elimination with a P-to-
eliminate value of > 0.05. All variables were categori-
cal with the exception of multimorbidity (number of
comorbidities), which was continuous. Age and sex
were forced into the model, because these were identi-
ﬁed as important confounding variables and general
practice was included as a random eﬀect [19–21]. Fati-
gue, psychological impairments and cognitive impair-
ments were analysed separately in three substudies.
Exploratory analysis investigated the impact of
excluding patients with presence of the outcome prior
to the index date for each substudy.
Results
The total cohort comprised 55 930 individuals (9419
TIA patients and 46 511 controls). The median age was
74 years (interquartile range 63, 82) and 48% were
males. Demographic and clinical characteristics of TIA
patients and controls are presented in Table 1.
Fatigue
A total of 55 754 individuals were included in the sur-
vival analysis for the fatigue substudy (9250 TIA
patients matched to 46 504 controls) (169 TIA patients
and 7 controls were excluded because fatigue was
recorded on the index date). The median follow-up was
17.2 (range 0–60.5) months for TIA patients and 19.1
(range 0–60.5) months for controls. Fatigue was
recorded in 3632 individuals (907 TIA patients and
2725 controls). The K-M curves show that TIA patients
were more likely to consult for fatigue compared with
controls (P < 0.0001; Fig. 1a). The 10th percentile for
time to fatigue was 20.7 months [95% conﬁdence inter-
val (CI), 18.6–23.5] for TIA patients and 42.4 months
(95% CI, 40.6–44.8) for controls (Fig. 1a). TIA patients
had a 43% increased risk of consulting for fatigue com-
pared with controls following adjustment for demo-
graphic and clinical characteristics [hazard ratio (HR)
1.43; 95% CI, 1.33–1.54; P < 0.0001, Table S2].
Psychological impairment
A total of 55 483 individuals were included in the sur-
vival analysis for the psychological impairment sub-
study (9240 TIA patients matched to 46 243 controls)
(179 TIA patients and 268 controls were excluded
because psychological impairment was recorded on
the index date). The median follow-up was 11.2 (range
0–60.5) months for TIA patients and 14.4 (range
0–60.5) months for controls. Psychological impair-
ment was recorded in 14 285 individuals (3159 TIA
patients and 11 126 controls). Of these, 11 040 con-
sulted for depression, 2691 for anxiety, 546 for anxiety
and depression, and 8 for PTSD. The K-M curves
show that TIA patients were more likely to consult
for/be prescribed drugs for psychological impairment
compared with controls (P < 0.0001; Fig. 1b). The
25th percentile for time to psychological impairment
was 7.1 months (95% CI, 6.2–8.2) for TIA patients
and 23.5 months (95% CI, 22.5–24.6) for controls
(Fig. 1b). Following adjustment for demographic and
clinical characteristics, TIA patients had a 26%
increased risk of consulting for psychological impair-
ment compared with controls (HR 1.26; 95% CI,
1.20–1.31; P < 0.0001, Table S3).
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Cognitive impairment
A total of 55 905 individuals were included in the sur-
vival analysis for the cognitive impairment substudy
(9397 TIA patients matched to 46 508 controls) (22
TIA patients and 3 controls were excluded because cog-
nitive impairment was recorded on the index date). The
median follow-up time was 18.8 (range 0–60.5) months
for TIA patients and 20.0 (range 0–60.5) months for
controls. Cognitive impairment was recorded in 1425
individuals (363 TIA patients and 1062 controls). The
K-M curves show that TIA patients were more likely to
consult for cognitive impairment compared with con-
trols (P < 0.0001; Fig. 1c). The 5th percentile for time
to cognitive impairment was 31.1 months (95% CI,
25.9–35.6) for TIA patients and 52.7 months (95% CI,
48.6–56.4) for controls (Fig. 1c). Following adjustment
for demographic and clinical characteristics, TIA
patients had a 45% increased risk of consulting for cog-
nitive impairment compared with controls (HR 1.45;
95% CI, 1.28–1.65; P < 0.0001, Table S4).
Exploratory analysis
Distinguishing between recurrent impairments after
the index date and ongoing impairments is diﬃcult.
Therefore, we explored the eﬀect of excluding individ-
uals with a record of the outcome prior to the index
Table 1 Demographic and clinical characteristics of transient ischae-
mic attack (TIA) patients and controls
Control TIA
Frequency % Frequency %
Total 46 511 100 9419 100
Age (years)
< 45 1416 3.0 279 3.0
45–49 1576 3.4 293 3.1
50–54 2378 5.1 495 5.3
55–59 3092 6.6 600 6.4
60–64 4338 9.3 879 9.3
65–69 5559 12.0 1120 11.9
70–74 6303 13.6 1247 13.2
75–79 7223 15.5 1502 15.9
80–84 6886 14.8 1378 14.6
85–89 5013 10.8 1009 10.7
≥ 90 2727 5.9 617 6.6
Sex
Male 22 245 47.8 4504 47.8
Smoking status
Non-smoker 23 435 50.4 4505 47.8
Ex-smoker 13 970 30.0 2964 31.5
Current 5748 12.4 1555 16.5
Missing 3358 7.2 395 4.2
Alcohol intakea
Never 5954 12.8 1212 12.9
Light 7930 17.0 1671 17.7
Moderate 5617 12.1 1165 12.4
High 12 624 27.1 2630 27.9
Missing 14 386 30.9 2741 29.1
BMIb
Healthy 14 872 32.0 2971 31.5
Underweight 944 2.0 199 2.1
Overweight 16 552 35.6 3469 36.8
Obese 10 220 22.0 2179 23.1
Missing 3923 8.4 601 6.4
Deprivation
1 (least deprived) 12 353 26.6 2383 25.3
2 11 171 24.0 2241 23.8
3 9399 20.2 1908 20.3
4 7635 16.4 1623 17.2
5 (most deprived) 4771 10.3 1073 11.4
Missing 1182 2.5 191 2.0
Rurality
Urban 17 642 37.9 3522 37.4
Rural 28 867 62.1 5893 62.6
Missing 2 0.0 4 0.0
Comorbidities
Atrial ﬁbrillation 3273 7.0 1055 11.2
Asthma 4909 10.6 1176 12.5
Cancer 4387 9.4 1074 11.4
CHD 6631 14.3 1680 17.8
CKD 7553 16.2 1779 18.9
COPD 2700 5.8 689 7.3
Dementia 1579 3.4 375 4.0
Depression 8109 17.4 2103 22.3
Diabetes 5734 12.3 1376 14.6
Epilepsy 618 1.3 199 2.1
Heart failure 1695 3.6 421 4.5
Hypertension 20 112 43.2 4617 49.0
(continued)
Table 1 (Continued)
Control TIA
Frequency % Frequency %
Hypothyroidism 4098 8.8 982 10.4
Learning disability 107 0.2 44 0.5
Osteoporosis 3128 6.7 770 8.2
PAD 1376 3.0 414 4.4
Palliative care 319 0.7 89 0.9
Psychosis 499 1.1 112 1.2
Rheumatoid arthritis 794 1.7 206 2.2
Impairment prior to index date
Fatigue 10 074 21.7 2910 30.9
Psychological
impairment
22 127 47.6 5396 57.3
Cognitive impairment 1983 4.3 664 7.0
Median consultations
in year post-index
date [IQR]
5 [210] 10 [6, 17]
CHD, coronary heart disease; CKD, chronic kidney disease; COPD,
chronic obstructive pulmonary disease; IQR, interquartile range;
PAD, peripheral artery disease.
aAlcohol intake: never (0 units/day); light (1–2 units/day); moderate
(3–6 units/day); high (≥ 7 unit/day); bBody mass index (BMI):
healthy (18.5–25.9 kg/m2); underweight (< 18.5 kg/m2); overweight
(26–30 kg/m2); obese (> 30 kg/m2).
© 2016 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.
4 G. M. TURNER ET AL.
date. In this exploratory analysis, 42 836 individuals
were included in the survival analysis for the fatigue
substudy (6400 TIA patients and 36 436 controls),
28 390 in the psychological impairment substudy
(4013 TIA patients and 24 377 controls) and 53 265
in the cognitive impairment substudy (8739 TIA
patients and 44 526 controls). Results showed that a
signiﬁcant diﬀerence between TIA patients and con-
trols remained for all three impairments (P < 0.0001;
Fig. 2). The 5th percentile for time to consultation for
fatigue was 15.9 months for TIA patients and
41.6 months for controls; the 10th percentile for time
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Figure 1 Kaplan–Meier (K-M) failure estimates for transient
ischaemic attack (TIA) patients and controls consulting for: (a)
fatigue, (b) psychological impairment and (c) cognitive impair-
ment. The maximum follow-up time was 60.5 months for each
substudy. However, the K-M graphs are cut-oﬀ at 48 months
when approximately < 10% of the sample remains.
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Figure 2 Kaplan–Meier (K-M) failure estimates for transient
ischaemic attack (TIA) patients and controls with no record of
the impairment prior to the index date and consulting for: (a)
fatigue, (b) psychological impairment and (c) cognitive impair-
ment. The maximum follow-up time was 60.5 months for each
substudy. However, the K-M graphs are cut-oﬀ at 48 months
when approximately < 10% of the sample remains.
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to consultation/drug prescription for psychological
impairment was 12.6 months for TIA patients and
24.2 months for controls; and the 5th percentile for
time to consultation for cognitive impairment was
24.9 months for TIA patients and 48.2 months for
controls. Adjusted HRs increased to 1.75 (95% CI,
1.57–1.94) for fatigue, 1.66 (95% CI, 1.50–1.84) for
psychological impairment and 1.54 (95% CI, 1.35–
1.77) for cognitive impairment.
Discussion
Clinically diagnosed TIA patients in a large UK gen-
eral practice population were more likely than
matched controls to consult for fatigue, psychological
impairment and cognitive impairment. Compared with
controls, TIA patients had an increased risk of 43%
for consulting for fatigue, 26% for psychological
impairment and 45% for cognitive impairment. These
diﬀerences remained after adjustment for potential
confounders and when patients with previous impair-
ments were excluded from the analysis. Our ﬁndings
suggest that, for many patients, TIA is not a transient
event and patients experience impairments after initial
symptoms have resolved.
The main strengths of our study include the very
large sample size (> 55 700 patients), data were avail-
able from diﬀerent regions across the UK and are rep-
resentative of the UK population, and data represent
real-life primary care practice. The study design
addressed limitations of existing studies in this ﬁeld by
including a control group and controlling for con-
founding variables, particularly the presence of fati-
gue, psychological or cognitive impairment prior to
the index date and comorbidities. Recording of these
impairments is likely to vary between general prac-
tices. We therefore matched TIA patients and controls
on this variable and included it as a random eﬀect in
the regression models.
A limitation of the study concerns the recording of
TIA in primary care. Although general practitioners
(GPs) are incentivized to keep a register of TIA
patients in the UK, TIA may be misdiagnosed
[22,23] or under-reported [24]. Misdiagnosis of a TIA
‘mimic’ (e.g. migraine with TIA-like symptoms) or
minor stroke as TIA may dilute or overestimate the
association between TIA and residual impairments,
respectively. However, diagnosis of TIA has been
validated in the THIN database [12]. There are also
limitations regarding the recording of our outcomes,
which rely on patients consulting with residual
impairment and clinicians recording these in patients’
electronic medical records. Clinical codes for signs
and symptoms were used in addition to clinical codes
for diagnoses to deﬁne our outcomes. Therefore, our
outcomes may not be equivalent to clinical diagnoses
of fatigue, psychological impairment or cognitive
impairment, e.g. there was no distinction between a
clinical diagnosis of anxiety and feeling anxious.
Stroke prevention medication was not included as a
confounder in the analysis. There is some evidence
that beta-blockers may cause fatigue [25]. However,
as they are not recommended as a ﬁrst-line treatment
for hypertension in this age group [26], it is unlikely
that many patients were prescribed them. Bias may
be introduced in our study because: (i) TIA patients
consulted more in follow-up and therefore would
have more opportunity to report impairment(s) and
(ii) patients may be more conscious of their health
following a TIA compared with controls, resulting in
increased reporting of impairments. It is important
to emphasize that not all patients who experienced
impairments post-TIA would have consulted their
GP about them in primary care. Therefore, our ﬁnd-
ings do not represent the incidence of residual
impairment post-TIA in the community. Finally, time
to consultation may not reﬂect the onset of the
impairments as patients may have waited before con-
sulting their GP.
The systematic review conducted prior to our
study found a limited number of studies that mea-
sured residual impairment after TIA and included a
control group [9]. None of the included studies that
measured fatigue or PTSD had a control group.
Only one study that measured anxiety included a
control group and found a statistically signiﬁcant dif-
ference in frequency of anxiety between TIA and
control patients [27]. However, two depression stud-
ies that included controls reported no diﬀerence
[27,28]. Three studies that measured cognitive impair-
ment and included a comparison group were
included in the systematic review [29–31]. Two of
these studies found a statistically signiﬁcant diﬀer-
ence in frequency of cognitive impairment between
TIA patients and controls. However, most of the
studies included in the systematic review that had a
control group did not adjust for confounding vari-
ables and the sample sizes were relatively small
(< 350 participants). Subsequent to the systematic
review, a Dutch study found a reduction in cognitive
functioning in TIA patients compared with controls
in all cognitive domains except episodic memory.
However, the sample size was relatively small
(n = 189) and the TIA patients and controls were
not matched [32]. Other studies conducted after our
systematic review that investigated psychological
impairment post-TIA did not include a control group
[33,34]. Our study addressed the limitations of
© 2016 The Authors. European Journal of Neurology published by John Wiley & Sons Ltd on behalf of European Academy of Neurology.
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existing studies and found an increased risk of
consulting for fatigue, psychological and cognitive
impairment in TIA patients compared with controls.
The mechanism of residual impairments post-TIA
is unknown. However, there are a number of poten-
tial explanations for our ﬁndings. Diagnoses of TIA
within our study would have been based on clinical
diagnosis rather than tissue-based diagnosis because
brain imaging is not routinely used to diagnose TIA
within the UK [5]. Therefore, patients may have had
cerebral infarction, which could be responsible for
the residual impairments and, by the tissue-based
deﬁnition of TIA, should be considered as a minor
stroke. A systematic review found evidence of ischae-
mic lesion in one-third of TIA patients diagnosed
according to the time-based deﬁnition [35]. Alterna-
tively, contrary to the tissue-based deﬁnition, TIA
may cause microinfarcts that are not detected by
neuroimaging with computed tomographic or mag-
netic resonance imaging. Microinfarcts have been
detected by histological examination, and pooled
analysis of autopsy studies from community prospec-
tive cohorts found an association between microin-
farcts and dementia [36]. Studies have found
evidence of abnormal neural activity in TIA patients
with no lesions on conventional magnetic resonance
imaging compared with controls [37,38]. Further-
more, these studies reported an association between
abnormal neural activity and cognitive impairment.
Another possible mechanism of residual impairments
post-TIA could the psychological impact of the
event. The psychological impact of TIA and minor
stroke has been described in qualitative research [39].
A psychological mechanism has been proposed for
post-stroke depression [40] and depression after
minor stroke has been found to be independent of
cerebral lesions [41]. Furthermore, an association
between depression and cognitive impairment has
been reported post-stroke [42].
Future research should establish the severity, onset,
duration and natural history of residual impairments
post-TIA. Additional research should develop inter-
vention(s) to identify TIA patients with fatigue, psy-
chological impairment or cognitive impairment and
improve the healthcare and rehabilitation of these
patients in a cost-eﬀective way. It is important for
future research to determine the impact that residual
impairments post-TIA have on quality of life and abil-
ity to return to work and social activities. Further-
more, research that investigates the mechanism
underlying the association between TIA and residual
impairments may facilitate the development of a reha-
bilitation intervention and could challenge the current
deﬁnition of TIA.
Conclusion
Transient ischaemic attack patients are more likely to
consult for fatigue, psychological and cognitive
impairment in primary care compared with controls.
These ﬁndings challenge the ‘transient’ characteriza-
tion of TIA and suggest that these patients may
require therapy beyond stroke prevention. Dissemina-
tion of our ﬁnding to primary care clinicians and pol-
icy makers is important to increase the detection and
treatment of residual impairments after TIA.
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